RARECast

RARECast

By RARECastBusiness
Download on the App Store

RARECast episodes

  • How Researchers Diagnosed Four Patients with a Never-Before-Identified Rare Disease in a Day
    Diagnosing a rare disease can take years. When it’s a disease that’s never been identified before, the search for a diagnosis can be that much more difficult. Daryl Scott, associate professor of molecular and human genetics at Baylor College of Medicine, and colleagues diagnosed four patients on two continents with a never before identified rare disease in a day. The feat is recounted in a recent study published in the journal PLoS ONE (http://bit.ly/2oEXhy5). We spoke to Scott about the diagnosis, how it all came together, and what it says about the role of data and collaboration in medical detective work today.
    26 min
  • Stem Cell Gene Therapy Restores Immune System in Kids with SCID
    Researchers at UCLA have developed a stem cell gene therapy treatment for children born with the rare, life-threatening condition ADA-deficient SCID, often referred to as Bubble Baby disease. Children born with this condition are without a functioning immune system and are kept in controlled and isolated environments because exposure to common illnesses or infections can be lethal. We spoke to the treatment’s developer Donald Kohn of the UCLA Eli and Edythe Broad Center of Regenerative Medicine about the stem cell gene therapy, the promising results he’s had restoring normal immune function in clinical trial patients, and why this approach holds promise in other rare conditions.
    20 min
  • Rare Disease Advocates Push for Incentives to Drugmakers Pulled from Cures Act
    Legislation that would provide incentives to drugmakers to repurpose existing pharmaceuticals as rare disease treatments is once again in the works. Known as The OPEN ACT (Orphan Product Extensions Now, Accelerating Cures and Treatments), proponents say it would help address a gap in the drug development landscape. At one point, the bill had been folded into the 21st Century Cures Act, but had been stripped out before passage. We spoke to Max Bronstein, chief advocacy and science policy officer for the Everylife Foundation for Rare Diseases, about the legislation, why its needed, and what it will take to get passed.
    19 min
  • Non-Profit Drug Company Seeks to Advance Rare Disease Therapies
    The high cost of drug development and the small populations for individual rare diseases can make it difficult to attract drug companies to make the investment of time, money, and resources necessary to bring a rare disease drug to market. American MedChem, a non-profit drug company, is hoping to bridge a gap between the lab and the clinic, by using its small molecule expertise to advance potential rare disease therapies to a point where a drug company might seek to license them. We spoke to Robert Selliah, founder, president, and CEO of American MedChem, about its business model, what a non-profit can do that a for-profit pharmaceutical company can’t, and how it is prioritizing the projects it is pursuing.
    28 min
  • Innovative Collaboration Model Drives Treatment for Rare Disease
    Rare disease advocates, because of their diseases’ small population of patients, can find it challenging to muster the interest of researchers and drug developers to invest the money, time, and energy needed to discover and develop a therapeutic. One solution is to drive collaborations to leverage the limited resources of foundations and researchers and advance their efforts to a point where drug company may be willing to take over development. Support of Accelerated Research for Niemann-Pick C, or SOAR-NPC, represents such a model. We spoke to Cristin Davidson, a researchers and project manager for SOAR-NPC, about the organization’s approach, how its tackled various preclinical challenges common to rare diseases, and why the success it has enjoyed should be replicated by others.
    26 min
  • Girl with Rare Disease Inspires Search for Bone Marrow Donors
    Hallie Bae Barnard is an eight-year-old girl with Diamond Blackfan Anemia, a rare condition that has set her family and friends on a search for a suitable bone marrow donor. But her understanding of the need of others in a similar situation has her on a quest to find not only a match for herself, but for many others who are unable to find a life-saving bone marrow donation they need. We spoke to Jennifer Scott, a founding board member and vice president of Media and Communications for Hallie’s Heroes, about Diamond Blackfan Anemia, the challenges of finding bone marrow donors, and the impact the organization is having.
    20 min
  • A Quest for Tribe: Searching for Others with the Same Ultra-Rare Mutation
    When Milo Lorentzen was born, concerns over his condition sent him to a neonatal intensive care unit where he spent the first ten days of his life. It began a medical and diagnostic odyssey for him and his parents. After six surgeries and undiagnosed global developmental delays, doctors identified a de novo gene mutation to his KDM1A/LSD1 gene that is believed to be the cause of his condition. His parents eventually launched the website Milo’s Journey to tell his story in the hopes of finding others with the same mutation. We spoke to Karen Park, Milo’s mother, about her family’s experience, the challenge of having a child with an ultra-rare disease of unknown consequence, and the experience of finding others with the same condition.
    18 min
  • Raising Awareness in a Town with a History of a Rare Disease
    Edgar Kline Jr.’s family can trace its involvement with a rare genetic disease back to the 1700s. In fact, Hagerstown, Maryland, where his family settled, has a higher incidence of hereditary ATTR amyloidosis because of this common ancestor some in the town share. The disease which begins to manifest itself in middle age, can cause damage to the heart, nerves, and various organs. We spoke to Kline about the disease, the difficulty in getting an accurate diagnosis, and why he’s trying to raise awareness about it.
    18 min
  • Helping Rare Disease Patients Navigate the World of Information
    The Internet has opened up a world of information to rare disease patients, but it can often be hard to access, understand, or evaluate. Raremark is working to keep rare disease patients up to date with the latest information about their conditions through its online community built around disease channels. We spoke to Raremark founder Julie Walters about the website, how it curates information, and how its ultimately seeking to empower rare disease patients to make better decisions about their own care.
    21 min
  • Overcoming the Challenges of Rare Disease Drug Development
    The translation of a drug from discovery to development faces a number of obstacles, but these can be amplified for rare disease therapies in part because of the smaller populations, heterogeneous nature, and often poorly understood development of a disease. The Catalyst program at the Clinical & Translational Science Institute at the University of California, San Francisco will be holding a one-day symposium on March 3 with leading researchers, drug developers, and patient advocates about the translational challenges rare disease therapies face and how to address them. We spoke to Cathy Tralau-Stewart, interim director of UCSF's Catalyst Program, about the upcoming symposium, the unique translational challenges rare disease therapies face, and what can be done to overcome them. To view the symposium agenda or to register, you can paste this URL (http://bit.ly/2lWmYbB) into your browser.
    20 min

About RARECast

From the publisher's feed

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.